United Therapeutics (UTHR) Misses Q1 EPS by 117c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $511.72 --0%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Interest expense: -500K
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $5.82, $1.17 worse than the analyst estimate of $6.99. Revenue for the quarter came in at $781.5 million versus the consensus estimate of $798.85 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Wells Fargo Upgrades SM Energy (SM) to Overweight
- Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
